Yoshinobu Ishiwata1, Tomohiro Kaneta2, Shintaro Nawata1, Ayako Hino-Shishikura1, Keisuke Yoshida1, Tomio Inoue1. 1. Department of Radiology, Yokohama City University, Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ward, Yokohama, Kanagawa, 236-0004, Japan. 2. Department of Radiology, Yokohama City University, Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ward, Yokohama, Kanagawa, 236-0004, Japan. kaneta@yokohama-cu.ac.jp.
Abstract
PURPOSE: Our aim was to assess whether 18F-NaF PET/CT is able to predict progression of the CT calcium score. METHODS: Between August 2007 and November 2015, 34 patients (18 women, 16 men; age, mean ± standard deviation, 57.5 ± 13.9 years; age range 19-78 years) with malignancy or orthopaedic disease were enrolled in this study, with approximately 1-year follow-up data. Baseline and follow-up CT images were retrospectively evaluated for the presence of calcification sites in major vessel walls. The maximum and mean CT values (CTmax and CTmean, in Hounsfield units), calcification volumetric score (CVS, in cubic millimetres) and Agatston units score (AU) were evaluated for each site. Subsequent changes in CTmax, CTmean, CVS and AU were calculated and expressed as ΔCTmax, ΔCTmean, ΔCVS and ΔAU, respectively. We then evaluated the relationship between 18F-NaF uptake (using the maximum target-to-background ratio, TBRmax, and the maximum blood-subtracted 18F-NaF activity, bsNaFmax, which was obtained by subtracting the SUVmax of each calcified plaque lesion and NaF-avid site from the SUVmean in the right atrium blood pool) and the change in calcified plaque volume and characteristics obtained after 1 year. RESULTS: We detected and analysed 182 calcified plaque sites and 96 hot spots on major vessel walls. 18F-NaF uptake showed very weak correlations with CTmax, CTmean, CVS, CVS after 1 year, AU and AU after 1 year on both baseline and follow-up PET/CT scans for each site. 18F-NaF uptake showed no correlation with ΔCTmax or ΔCTmean. However, there was a significant correlation between the intensity of 18F-NaF uptake and ΔCVS and ΔAU. CONCLUSION: 18F-NaF uptake has a strong correlation with calcium score progression which was a predictor of future cardiovascular disease risk. PET/CT using 18F-NaF may be able to predict calcium score progression which is known to be the major characteristic of atherosclerosis.
PURPOSE: Our aim was to assess whether 18F-NaF PET/CT is able to predict progression of the CT calcium score. METHODS: Between August 2007 and November 2015, 34 patients (18 women, 16 men; age, mean ± standard deviation, 57.5 ± 13.9 years; age range 19-78 years) with malignancy or orthopaedic disease were enrolled in this study, with approximately 1-year follow-up data. Baseline and follow-up CT images were retrospectively evaluated for the presence of calcification sites in major vessel walls. The maximum and mean CT values (CTmax and CTmean, in Hounsfield units), calcification volumetric score (CVS, in cubic millimetres) and Agatston units score (AU) were evaluated for each site. Subsequent changes in CTmax, CTmean, CVS and AU were calculated and expressed as ΔCTmax, ΔCTmean, ΔCVS and ΔAU, respectively. We then evaluated the relationship between 18F-NaF uptake (using the maximum target-to-background ratio, TBRmax, and the maximum blood-subtracted 18F-NaF activity, bsNaFmax, which was obtained by subtracting the SUVmax of each calcified plaque lesion and NaF-avid site from the SUVmean in the right atrium blood pool) and the change in calcified plaque volume and characteristics obtained after 1 year. RESULTS: We detected and analysed 182 calcified plaque sites and 96 hot spots on major vessel walls. 18F-NaF uptake showed very weak correlations with CTmax, CTmean, CVS, CVS after 1 year, AU and AU after 1 year on both baseline and follow-up PET/CT scans for each site. 18F-NaF uptake showed no correlation with ΔCTmax or ΔCTmean. However, there was a significant correlation between the intensity of 18F-NaF uptake and ΔCVS and ΔAU. CONCLUSION:18F-NaF uptake has a strong correlation with calcium score progression which was a predictor of future cardiovascular disease risk. PET/CT using 18F-NaF may be able to predict calcium score progression which is known to be the major characteristic of atherosclerosis.
Authors: Alexandra E Ewence; Martin Bootman; H Llewelyn Roderick; Jeremy N Skepper; Geraldine McCarthy; Matthias Epple; Markus Neumann; Catherine M Shanahan; Diane Proudfoot Journal: Circ Res Date: 2008-07-31 Impact factor: 17.367
Authors: Agnese Irkle; Alex T Vesey; David Y Lewis; Jeremy N Skepper; Joseph L E Bird; Marc R Dweck; Francis R Joshi; Ferdia A Gallagher; Elizabeth A Warburton; Martin R Bennett; Kevin M Brindle; David E Newby; James H Rudd; Anthony P Davenport Journal: Nat Commun Date: 2015-07-07 Impact factor: 14.919
Authors: William S A Jenkins; Alex T Vesey; Anoop S V Shah; Tania A Pawade; Calvin W L Chin; Audrey C White; Alison Fletcher; Timothy R G Cartlidge; Andrew J Mitchell; Mark A H Pringle; Oliver S Brown; Renzo Pessotto; Graham McKillop; Edwin J R Van Beek; Nicholas A Boon; James H F Rudd; David E Newby; Marc R Dweck Journal: J Am Coll Cardiol Date: 2015-09-08 Impact factor: 24.094
Authors: Jamie W Bellinge; Roslyn J Francis; Sing Ching Lee; Alistair Vickery; William Macdonald; Seng Khee Gan; Gerard T Chew; Michael Phillips; Joshua R Lewis; Gerald F Watts; Carl J Schultz Journal: J Nucl Cardiol Date: 2021-04-06 Impact factor: 3.872
Authors: Antonio Gutierrez-Cardo; Eugenia Lillo; Belén Murcia-Casas; Juan Luis Carrillo-Linares; Francisco García-Argüello; Purificación Sánchez-Sánchez; Alejandro Rodriguez-Morata; Isabel Baquero Aranda; Miguel Ángel Sánchez-Chaparro; María García-Fernández; Pedro Valdivielso Journal: J Clin Med Date: 2020-05-08 Impact factor: 4.241